Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City

Public Health Reports

Volumn 122, Issue 3, 2007, Pages 393-397

  Heller, Daliah I ^a   Stancliff, Sharon ^b  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b Harm Reduction Coalition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; NALOXONE; NARCOTIC ANTAGONIST;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG OVERDOSE; FATALITY; HEALTH HAZARD; HOMICIDE; HUMAN; MORTALITY; PRIORITY JOURNAL; PRISON; PUBLIC HEALTH SERVICE; REVIEW; SUBSTANCE ABUSE; UNITED STATES; ARTICLE; DRUG LEGISLATION; EMERGENCY TREATMENT; HEALTH EDUCATION; INTOXICATION; METHODOLOGY; OPIATE ADDICTION; ORGANIZATION AND MANAGEMENT;

EMERGENCY TREATMENT; HEALTH EDUCATION; HUMANS; LEGISLATION, DRUG; NALOXONE; NARCOTIC ANTAGONISTS; NEW YORK CITY; OPIOID-RELATED DISORDERS; OVERDOSE;

EID: 34250342670     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335490712200313     Document Type: Review

References (24)

1. Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in drug overdose deaths in New York City, 1990-1998. Addiction 2003;98:739-747
2. Kerker B, Bainbridge J, Li W, Kennedy J, Bennani Y, Agerton T, et al. The health of the homeless: a report from New York City's Departments of Health and Mental Hygiene and Homeless Services, 2005.
3. Pfeiffer M, Hanna DB, Begier EM, Sepkowitz KA, Torian LV, Sackoff JE. Persistent contribution of substance abuse to excess mortality among persons with AIDS in New York City, 1999-2003. Presentation at the 16th International AIDS Conference; 2006 Aug 13-18; Toronto, Ontario, Canada.
4. Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison - a high risk of death for former inmates. N Engl J Med 2007;356:157-165
5. Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend 2005;80:297-302. (Pubitemid 41660850)
6. Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-1999. Addiction 2003;98:185-190
7. Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ 1998;316:426-428 (Pubitemid 28121295)
8. Sporer KA, Kral AH. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007;49:172-177 (Pubitemid 46127584)
9. Baca CT, Grant KJ. Take-home naloxone to reduce heroin death. Addiction 2005;100:1823-1831.
10. Tracy M, Piper TM, Ompad D, Bucciarelli A, Coffin PO, Vlahov D, et al. Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend 2005;79:181-190
11. Lagu T, Anderson BJ, Stein M. Overdoses among friends: Drug users are willing to administer naloxone to others. J Subst Abuse Treat 2006;30:129-133
12. Riley D, O'Hare P. Harm reduction: history, definition, and practice. In: Inciardi JA, Harrison LD, editors. Harm reduction: national and international perspectives. Thousand Oaks (CA): Sage; 2000. p. 1-26.
13. Markham Piper T, Rudenstine S, Stancliff S, Sherman S, Nandi V, Clear A, et al. Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J 2007;4:3.
14. New York State Department of Health AIDS Institute. Harm Reduction Initiative [cited 2007 Jan 27]. Available from: URL: http://www.health.state.ny. us/diseases/aids/about/prevsup.htm#harmred
15. Nandi A, Galea S, Ahern J, Bucciarelli A, Vlahov D, Tardiff K. What explains the association between neighborhood-level income inequality and the risk of fatal overdose in New York City? Soc Sci Med 2006;63:662-674
16. Hembree C, Galea S, Ahern J, Tracy M, Piper TM, Miller J, et al. The urban built environment and overdose mortality in New York City neighborhoods. Health Place 2005;11:147-156
17. Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, Rosenthal DM. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. J Addic Behav 2006;31:907-912
18. New York State Public Health Law A7162-A. An act to amend the public health law, in relation to opioid overdose prevention [cited 2006 Dec 5]. Available from: URL: http://nysosc9.osc.state.ny.us/product/mbrdoc.nsf/0/ 1a165db3facebf7785257099004a17a4?OpenDocument
19. New York State Public Health Law Section 3309(1), Part 80.138. Opiate overdose prevention: programs in New York State [cited 2006 Oct 11]. Available from: URL: http://www.health.state.ny.us/diseases/aids/harm-reduction/ opioidprevention/index.htm
20. Candelas A. Applying national overdose prevention experience to local policy implementation. Presentation at the 6th National Harm Reduction Conference; 2006 Nov 11; Oakland, CA.
21. Open Society Institute, OSI-Baltimore. Health experts hold forum on highly successful Baltimore overdose prevention program [press release]; 2005 Sep 20 [cited 2006 Nov 17]. Available from: URL: http://www.soros.org/ initiatives/baltimore/news/health-20050920
22. Ashton H, Hassan Z. Best evidence topic report. Intranasal naloxone in suspected opioid overdose. Emerg Med J 2006;23:221-223
23. Kelly AM, Kerr D, Dietze P, Patrick I, Walker T, Koutsogiannis Z. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Aust 2005;182:24-27 (Pubitemid 40089873)
24. Coffin PO, Fuller C, Vadnai L, Blaney S, Galea S, Vlahov D. Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health 2003;80:288-290 (Pubitemid 37486664)